Q2 2026 Progyny Inc Earnings Call Transcript
Key Points
- Record quarterly revenue, gross profit, and adjusted EBITDA in Q2 2026, with revenue up 5.3% year-over-year (11% excluding transition agreement impact).
- Gross margin expanded by 180 basis points year-over-year, driven by efficiencies in care management and service delivery.
- Strong selling season momentum with early commitments for new clients pacing meaningfully ahead of last year, positioning the company to meet its target of adding 1 million or more new lives.
- High client retention with most attrition risk for 2027 already de-risked, led by strong renewals from largest clients.
- Continued strong cash flow generation, with over $50 million in operating cash flow for the fourth time in five quarters and DSO improved by more than 7 days year-over-year.
- Significant shareholder returns through share repurchases, reducing shares outstanding by approximately 12.5% since November.
- Strategic progress in health plan partnerships and the new fully insured offering, Progyny Select, with a growing pipeline for future growth.
- Slightly more pronounced summer seasonality in member engagement, leading to a modest downward adjustment in Q3 guidance.
- Revenue growth for the full year is projected at 5.5% to 7.5% (9.7% to 11.7% excluding transition agreement), reflecting a slowdown from prior years.
- Continued investment in platform expansion and new offerings like Progyny Select is expected to pressure operating expenses, with adjusted EBITDA margin growth lagging gross margin expansion.
- The transition of a large former client under a care agreement ended in Q2 2025, creating a headwind to year-over-year revenue comparisons.
- Progyny Select is not expected to be a meaningful contributor to 2027 results, with the focus on building channel partnerships rather than driving volume.
- The competitive environment remains active, with other solutions in the market, though Progyny believes it differentiates on cost, quality, and member satisfaction.
Talking with you soon, please hold the line and we'll be right back. Thanks for holding, we appreciate your time and patience. Please stay on the line, and we will be back in just a moment. 1. Good day, ladies and gentlemen, and welcome to the Progeny Inc. Second quarter 2026 earnings conference call. At this time, all participants are on a listen-only mode, and the floor will be open for questions and comments after the presentation. If you wish to join the queue at any time to ask a question, you can press star 1 on your telephone keypad. Should you wish to remove yourself from queue, you can press 2. It is now my pleasure to turn the call over to your host, James Hart. James, the floor is yours.
Thank you, Tom, and good afternoon, everyone. Welcome to our second quarter conference call with me today are Panevski, CEO of Progeny, and Mark Livingston, CFO. We will begin with some prepared remarks before we open the call for your questions. Before we begin, I'd like to remind you that our comments
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
